Role of FMRP in rapid antidepressant effects and synapse regulation
Preprint
Abstract
Rapid antidepressants are novel treatments for major depressive disorder (MDD) and work by blocking N-methyl-aspartate receptors (NMDAR), which, in turn, activate the protein synthesis pathway regulated by mechanistic/mammalian target of rapamycin complex 1 (mTORC1). Our recent work demonstrates that the RNA-binding protein Fragile X Mental Retardation Protein (FMRP) is downregulated in dendrites upon treatment with a rapid antidepressant. Here, we show that the behavioral effects of the rapid antidepressant Ro-25-6981 require FMRP expression, and treatment promotes differential mRNA binding to FMRP in an mTORC1-dependent manner. Further, these mRNAs are identified to regulate transsynaptic signaling. Using a novel technique, we show that synapse formation underlying the behavioral effects of Ro-25-6981 requires GABA B R-mediated mTORC1 activity in WT animals. Finally, we demonstrate that in an animal model that lacks FMRP expression and has clinical relevance for Fragile X Syndrome (FXS), GABA B R activity is detrimental to the effects of Ro-25-6981. These effects are rescued with the combined therapy of blocking GABA B Rs and NMDARs, indicating that rapid antidepressants alone may not be an effective treatment for people with comorbid FXS and MDD.Keywords
All Related Versions
- Published version: Molecular Psychiatry, 26 (6), 2350.
This publication has 59 references indexed in Scilit:
- A historical review of antidepressant effects of ketamine and its enantiomersPharmacology Biochemistry and Behavior, 2020
- Ketamine: A Paradigm Shift for Depression Research and TreatmentNeuron, 2019
- Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicideF1000Research, 2018
- FMRP regulates an ethanol-dependent shift in GABABR function and expression with rapid antidepressant propertiesNature Communications, 2016
- Neuronal RNA‐binding proteins in health and diseaseWIREs RNA, 2014
- Signaling pathways underlying the rapid antidepressant actions of ketamineNeuropharmacology, 2012
- Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategiesNeurobiology of Learning and Memory, 2011
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Neuronal RNA Granules: Movers and MakersNeuron, 2006
- 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal modelsEuropean Journal of Pharmacology, 1991